SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

被引:0
|
作者
Alonso-Gordoa, Teresa [1 ]
Jimenez-Fonseca, Paula [2 ]
Martinez-Trufero, Javier [3 ]
Navarro, Miguel [4 ]
Porras, Ignacio [5 ]
Rubio-Casadevall, Jordi [6 ]
Arregui Valles, Marta [7 ]
Baste, Neus [8 ]
Hernando, Jorge [9 ]
Iglesias Docampo, Lara [10 ]
机构
[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
[2] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain
[3] Hosp Univ Miguel Servet, Med Oncol Dept, Zaragoza, Spain
[4] Complejo Asistencial Univ Salamanca, Med Oncol Dept, IBSAL, Salamanca, Spain
[5] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Med Oncol Dept, Cordoba, Spain
[6] Hosp Josep Trueta, Catalan Inst Oncol Girona, Girona Biomed Res Inst IDIBGI, Med Oncol Dept,ONCOGIRPRO Grp, Girona, Spain
[7] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain
[8] Hosp Clin Barcelona, Med Oncol Dept, IDIBAPS, Barcelona, Spain
[9] Hosp Univ Vall DHebron, Med Oncol Dept, Gastrointestinal & Endocrine Tumor Unit, VHIO, Barcelona, Spain
[10] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期
关键词
Thyroid carcinoma; Molecular alterations; Multidisciplinary; Systemic treatment; PHASE-II TRIAL; ASSOCIATION GUIDELINES; DOUBLE-BLIND; LOCOREGIONAL RECURRENCE; RISK STRATIFICATION; NECK DISSECTION; OPEN-LABEL; CARCINOMA; MANAGEMENT; PAPILLARY;
D O I
10.1007/s12094-024-03736-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have optimized treatment decisions based on risk assessment, molecular profiling, and imaging assessment, leading the development of targeted agents that have modified the natural history of this disease. This increasing complexity on treatment options requires careful assessment at the different stages of the disease to provide the most suitable approach from diagnosis to long-term follow-up. This guideline aims to offer a comprehensive and practical overview on the current status and last updates of TC management.
引用
收藏
页码:2902 / 2916
页数:15
相关论文
共 50 条
  • [11] SEOM clinical guideline in nasopharynx cancer (2017)
    Pastor, M.
    Lopez Pousa, A.
    del Barco, E.
    Perez Segura, P.
    Gonzalez Astorga, B.
    Castelo, B.
    Bonfill, T.
    Martinez Trufero, J.
    Jose Grau, J.
    Mesia, R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 84 - 88
  • [12] SEOM Clinical Guideline in ovarian cancer (2016)
    Santaballa, A.
    Barretina, P.
    Casado, A.
    Garcia, Y.
    Gonzalez-Martin, A.
    Guerra, E.
    Lainez, N.
    Martinez, J.
    Redondo, A.
    Romero, I.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12): : 1206 - 1212
  • [13] SEOM clinical guideline in ovarian cancer (2020)
    Redondo, A.
    Guerra, E.
    Manso, L.
    Martin-Lorente, C.
    Martinez-Garcia, J.
    Perez-Fidalgo, J. A.
    Varela, M. Q.
    Rubio, M. J.
    Barretina-Ginesta, M. P.
    Gonzalez-Martin, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (05): : 961 - 968
  • [14] Clinical guideline seom: hereditary colorectal cancer
    C. Guillén-Ponce
    R. Serrano
    A. B. Sánchez-Heras
    A. Teulé
    I. Chirivella
    T. Martín
    E. Martínez
    R. Morales
    L. Robles
    Clinical and Translational Oncology, 2015, 17 : 962 - 971
  • [15] Thyroid cancer: SEOM clinical guidelines
    J. M. Trigo
    J. Capdevila
    E. Grande
    J. Grau
    P. Lianes
    Clinical and Translational Oncology, 2014, 16 : 1035 - 1042
  • [16] Thyroid cancer: SEOM clinical guidelines
    Trigo, J. M.
    Capdevila, J.
    Grande, E.
    Grau, J.
    Lianes, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (12): : 1035 - 1042
  • [17] SEOM clinical guideline on hereditary colorectal cancer (2019)
    Guillen-Ponce, C.
    Lastra, E.
    Lorenzo-Lorenzo, I
    Martin Gomez, T.
    Morales Chamorro, R.
    Sanchez-Heras, A. B.
    Serrano, R.
    Soriano Rodriguez, M. C.
    Soto, J. L.
    Robles, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02): : 201 - 212
  • [18] Clinical guideline SEOM: cancer of unknown primary site
    Collado Martin, R.
    Garcia Palomo, A.
    de la Cruz Merino, L.
    Borrega Garcia, P.
    Baron Duarte, F. J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (12): : 1091 - 1097
  • [19] SEOM clinical guideline for treatment of cancer pain (2017)
    Jara, C.
    del Barco, S.
    Gravalos, C.
    Hoyos, S.
    Hernandez, B.
    Munoz, M.
    Quintanar, T.
    Meana, J. A.
    Rodriguez, C.
    de las Penas, R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 97 - 107
  • [20] SEOM clinical guideline for treatment of kidney cancer (2017)
    Gallardo, E.
    Mendez-Vidal, M. J.
    Perez-Gracia, J. L.
    Sepulveda-Sanchez, J. M.
    Campayo, M.
    Chirivella-Gonzalez, I.
    Garcia-del-Muro, X.
    Gonzalez-del-Alba, A.
    Grande, E.
    Suarez, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 47 - 56